1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Among these, S6 said a resident (R1) had scabies. S6 was not sure if R1’s family had been notified, and was not sure if R1 was treated for scabies. In interviews, S4, S5, S9, S10, and S13 said R1 did not have scabies or any rashes. S7 said R1 did not have scabies, but had a rash, and was itchy. S7 was not sure if R1 was being treated for the rash. S11 said R1 did not have scabies, but said R1 had redness on the chest and back. S11 was not sure what the redness was caused by, and was not sure what treatments R1 received for the redness. S12 said R1 was never confirmed to have had scabies, but was itchy.
LPA Moleski interviewed five residents (R2-R6). None of the residents remembered R1.
LPA Moleski reviewed R1’s file. R1’s Medication Administration Records (MARs) for the months of July through October 2023 did not show any treatments for scabies. R1’s centrally stored medication records dated between 1/4/23 and 10/23/23 did not show any medications that treat scabies. LPA Moleski reviewed a line listing of residents provided by the facility that identified R1 as “asymptomatic.” The line listing states that R1 received a dose of an antiparasitic medication on 8/10/23. Mulkey and S3 said this was a prophylactic treatment.
LPA Moleski reviewed progress notes written by facility staff dated between 4/30/23 and 10/25/23 and hospice notes dated between 7/31/23 and 10/24/23. A progress note written by staff on 8/10/23 stated that “Resident received” an antiparasitic medication “for prophylactic tx of scabies.” A progress note written on 10/11/23 states that there were “no skin concerns at this time.” A series of notes written between 10/2/23 and 10/16/23 describe "redness" to R1’s groin and genitalia, which did not cause signs or symptoms of pain or discomfort, according to the notes. Hospice nurses treated the area with barrier cream, according to the notes. A progress note written on 10/20/23 states that there were "no skin issues reported at this time." No further notes describe any skin issues.
In interviews, Mulkey, S2, S3, S4, S5, S6, S9, S10, and S11 said residents were treated prophylactically. Mulkey, S2, S5 and S9 said prophylactic treatments were attempted for as many residents as possible, as a precaution. S3 said prophylactic treatments were arranged for asymptomatic residents. S4 and S10 said residents suspected of having scabies were treated. S11 said residents at high risk for scabies or who had unidentified rashes were treated. S12 said only residents who had scabies were treated.
[continued on 9099-C] |